GridAI Technologies Corp. (GRDX)
$3.96-$0.05 (-1.22%) Today
GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 3 | 540,000 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
3 Form 4 filings on record, the earliest from Oct 10, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jason David Sawyer - Officer | Grant or award | Common Stock | 250,000 | $0.00 | - | |
| Jason David Sawyer - Officer | Grant or award | Common Stock | 250,000 | $0.00 | - | |
| Jack Syage - Director | Grant or award | Common Stock | 40,000 | $0.00 | - | |
| Sarah Romano - Officer | Open-market sale | Common Stock | 476 | $1.34 | $212 |
GridAI Technologies Corp. (GRDX) had 2 insider filings in the last 90 days, with the most recent on 2026-07-02. The full record for GRDX runs to 3 Form 4 filings, the earliest from 2024-10-10. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of GRDX were filed in the last 90 days.
No insider sales of GRDX were filed in the last 90 days. 1 sale is on record for this company.
This page tracks GRDX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add GRDX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
